Efficacy, safety of switching to latanoprostene bunod 0.024% in patients with OAG and OHT
The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease
The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease
BOSTON — In this Healio Video Perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses the Teneo excimer laser platform.
Two physicians provided their thoughts on diagnosis of normal tension glaucoma, establishing true progression, and how to manage worsening disease in this patient population
By Walter Bethke, Editor in Chief W e’ ve all known that person — or maybe we’ ve been that person — who avoids going…
Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice…
This case report describes a diagnosis of morning glory syndrome in a 2-week-old infant who presented with divergent strabismus, cleft lip, and hypertelorism.
Unveiling the Power List – a comprehensive ranking of the top 100 most influential ophthalmologists worldwide. Browse the list to find leading eye care experts,…
This case series describes 3 initially culture-negative cases of acute, severe, posterior-segment intraocular inflammation events occurring within the same month following faricimab intravitreal injections at…
Researchers examined disparities in service coverage of pediatric ophthalmologists and pediatric optometrists in relation to patient demographics to cast a light on at-risk populations and…
The company announced results from a Phase IV study of tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5% (Mydcombi) designed to characterize the efficacy and duration…